Trials / Not Yet Recruiting
Not Yet RecruitingNCT06476626
Maternal Reflective Functioning During the Transition to Motherhood
Maternal Reflective Functioning During the Transition to Motherhood as a Protective Factor in the Relationship Between Personal and Environmental Characteristics and the Mental Health of Both the Mother and the Infant
- Status
- Not Yet Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 200 (estimated)
- Sponsor
- University of Haifa · Academic / Other
- Sex
- Female
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
The goal of this clinical trial is to learn about Maternal Reflective Function (MRF) during the transition to motherhood. The main questions it aims to answer are: Does MRF mediates the connection between risk factors for mental health difficulties during first pregnancy and motherhood (the transition to motherhood) and outcomes related to the mother, the infant, and their relationship. Participants will: Answer questionnaires and clinical interviews during pregnancy and after birth of the first child (twice at third trimester, 1 and 3 months after birth). intervention group will participate in an online short intervention to enhance MRF.
Detailed description
Using this trial, the investigators will be able to better understand rather MRF moderate the connection between risk factors to outcomes after birth related to both the mother and the infant. Using RCT design we will be able to understand mechanism of change.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Maternal Reflective Function Workshop | 4 session group online intervention focused on psycho-educational knowledge regarding emotional regulation and specifically MRF. group size- up to 15 participants. 2 sessions will be during pregnancy and 2 sessions will taken place 1 and 3 months after birth. |
Timeline
- Start date
- 2024-07-15
- Primary completion
- 2026-08-30
- Completion
- 2027-08-30
- First posted
- 2024-06-26
- Last updated
- 2024-07-09
Locations
1 site across 1 country: Israel
Source: ClinicalTrials.gov record NCT06476626. Inclusion in this directory is not an endorsement.